Magsayo, Novie Jane J.
HRN: 28-13-78 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2025
CEFUROXIME 500MG (TAB)
11/21/2025
11/28/2025
PO
500mg
BID X 7 Days
Thickly MSAF; RMLE
Checking Initial Appropriateness
11/21/2025
MEBENDAZOLE 500MG (TAB)
11/21/2025
11/28/2025
PO
500mg
TID X 7 Days
Thickly MSAF; RMLE
Checking Initial Appropriateness
11/22/2025
CEFUROXIME 1.5GM (VIAL)
11/22/2025
11/23/2025
IV
1.5 G
Q8
Urinary Tract Infection
Checking Initial Appropriateness
11/23/2025
METRONIDAZOLE 500MG (TAB)
11/23/2025
11/28/2025
PO
500mg
TID
THICKLY MSAF
Checking Initial Appropriateness
11/23/2025
CEFUROXIME 500MG (TAB)
11/23/2025
11/28/2025
PO
500mg
BID
THICKLY MSAF
Checking Initial Appropriateness